Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BSRC - BioSolar Inc - OTC BB
"BioSolar, Inc. has developed a breakthrough technology to produce bio-based materials from renewable plant sources that will reduce the cost per watt of solar cells. Most of the solar industry is focused on photovoltaic efficiency to reduce cost. BioSolar is the first company to introduce a new dimension of cost reduction by replacing petroleum-based plastic solar cell components with durable bio-based materials. To learn more about BioSolar, please visit our website at http://www.biosolar.com "
CABN - Carbon Sciences Inc - OTC BB
"Carbon Sciences Inc. is developing a breakthrough technology to transform carbon dioxide (CO2) emissions into the basic fuel building blocks required to produce gasoline, diesel fuel, jet fuel and other portable fuels. Innovating at the intersection of chemical engineering and bio-engineering disciplines, we are developing a scalable biocatalytic process to meet the fuel needs of the world. Our solution to energy and climate challenges is a sustainable world of fuel consumption and climate stability by transforming CO2 into fuel. For example, Carbon Sciences' breakthrough technology can be used to transform CO2 emitted from fossil fuel power plants into gasoline to run cars and jet fuel to fly aircraft. To learn more about Carbon Sciences, please visit our website at http://www.carbonsciences.com "
forgot one...
AEMD - Aethion Medical Inc - OTC BB
"Aethlon Medical is the developer of the Hemopurifier®, a first-in-class medical device designed to treat infectious disease. The Hemopurifier® provides real-time therapeutic filtration of infectious viruses and immunosuppressive particles, and is positioned to address the treatment of drug and vaccine resistant viruses. Additionally, the device holds promise in cancer care, as research studies have verified the Hemopurifier® is able to capture immunosuppressive particles secreted by tumors. The Hemopurifier® is designed to act both as a stand-alone therapeutic, and as an adjunct treatment to enhance clinical benefit of established therapies. Pre-clinical studies conducted by researchers representing leading government and non-government health organizations both in the United States and abroad have documented the effectiveness of the Hemopurifier® in capturing from circulation the viruses that constitute pandemic threats, including H5N1 Avian Influenza (bird flu), and Dengue Hemorrhagic Fever (DHF) from circulation. The company is conducting studies to support the use of the Hemopurifier® as a broad-spectrum treatment countermeasure against bioterror threats, including Smallpox, and Ebola, Marburg, and Lassa hemorrhagic fever. Regulatory and commercialization initiatives in the United States are presently focused on bioterror threats, while international initiatives are directed toward naturally evolving pandemic threats, and chronic infectious disease conditions including the Human Immunodeficiency Virus (HIV) and Hepatitis-C (HCV). Aethlon demonstrated the safety of the Hemopurifier® in a 24-treatment human study at the Apollo Hospital in Delhi, India, and is currently conducting further human studies at the Fortis Hospital, also located in Delhi. The company has submitted an investigational device exemption (IDE) to the U.S. Food and Drug Administration (FDA) to advance the Hemopurifier® as a broad-spectrum treatment countermeasure against category “A” bioterror threats. Additional information regarding Aethlon Medical and its Hemopurifier® technology is available online at www.aethlonmedical.com."
i have come across NNVC a few times in the past but have done limited DD. they are on my AIDS stock list however...
NNVC - NanoViricides Inc - OTC BB
"NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H5N1 bird flu, seasonal influenza, HIV, EKC, hepatitis C, rabies, dengue fever, and Ebola virus, among others."
GOVX - GeoVax Labs Inc - OTC BB
"GeoVax Labs, Inc. is a biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's AIDS vaccine technology is the subject of 20 issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to prevent Acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, should the person ever become infected. GeoVax AIDS vaccines also may be effective as therapeutics, treatment of people already infected with AIDS virus.
GeoVax's core AIDS vaccine technologies were developed by Dr. Harriet Robinson, Senior V.P. of Research and Development, through a collaboration of colleagues at Emory University's Vaccine Center, the National Institutes of Health (NIH), The Centers for Disease Control and Prevention (CDC) and GeoVax.
GeoVax AIDS vaccines have moved forward in human clinical trials conducted by the HIV Vaccine Trials Network (HVTN) based in Seattle, Washington. The HVTN, funded through a cooperative agreement with the National Institutes of Health (NIH), is the largest worldwide clinical trials program dedicated to the development and testing of AIDS vaccines. Preclinical work enabling evaluation of GeoVax DNA and MVA vaccines was funded and supported by NIAID, which provided additional support to GeoVax AIDS vaccine development program with a $15 million IPCAVD grant awarded in late 2007."
MYMX - Mymetics Corp - OTC BB
"Mymetics' primary objective is to develop vaccines and therapies to prevent and treat the effects of certain retroviruses and other infectious diseases, including the human immunodeficiency virus, or HIV, the virus that leads to acquired immunodeficiency syndrome, or AIDS. Mymetics has also recently acquired from a close scientific partner an advanced malaria vaccine project currently in phase Ib clinical trial. Additional applications of Mymetics's research include potential treatments and/or vaccines for human oncoviral leukemias, multiple sclerosis, and organ transplantation."
spooky -
do you know about NNVC?
if it's not the "technology" that you had in mind, sorry for posting up, however -
they are developing unique biomedical solutions to a certain type of virus which includes: HIV, ebola, bird flu, dengue fever, and an eye virus called EKC -
their EKC product has shown "significant efficacy in early trials" -
board mark - keep up the good work -
AXVC - Axial Vector Engine Corp - Pink Sheets
"Axial Vector Energy Corporation (AVEC) is a global solutions provider that owns, develops and licenses revolutionary internal combustion engine and electric power generator technologies that have unlimited potential in military, industrial and commercial applications. AVEC and its partners are positioned to become unrivalled leaders in international engine and energy markets with technologies that produce more efficient, cost effective, environmentally sensitive and versatile solutions for use in a wide variety of important applications around the world."
XDSL - mPhase Technologies Inc - OTC BB
"mPhase Technologies, Inc. is a U.S. based microfluidic and nanotechnology specialist. Through its wholly owned subsidiary AlwaysReady, Inc., mPhase is focused on developing and commercializing its first nanotechnology based product. This new battery technology is based on a well-patented phenomenon known as electrowetting, which provides a unique way to store energy and manage power that will revolutionize the battery industry. For more information please visit our website at www.mPhaseTech.com"
AESO - Atlantic Energy Solutions Inc - Pink Sheets
"Atlantic Energy, founded in 1992, is a globally accredited Energy Efficiency and Resource Company and member of NAESCO (www.Naesco.org) that identifies, implements and finances energy efficiency projects designed to improve the overall efficiency of energy, water usage and renewable resources, reducing our dependency on foreign oil and diminishing our carbon footprint.
Headquartered in Saratoga Springs, NY and with a satellite office in Fairfield, NJ, Atlantic Energy Solutions assesses the energy demands and usages of municipal, corporate and industrial complexes to improve conservation and apply measures to boaster savings at the consumer level. The company incorporates the latest technologies, including wind and solar energy generation and other renewable resources focusing on energy and financial strategies to achieve comprehensive, innovative and cost-beneficial improvements."
BKYI - BIOkey International Inc - OTC BB
"BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions and information services to law enforcement departments, public safety agencies, government and private sector customers. BIO-key's mobile wireless technology provides first responders with critical, reliable, real-time data and images from local, state and national databases. BIO-key's high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise data to improve security, convenience and privacy and to reduce identity theft. Over 750 police departments in North America use BIO-key solutions, making BIO-key the leading supplier of mobile and wireless solutions for law enforcement. (http://www.bio-key.com)"
AXPW - Axion Power International Inc - OTC BB
"Axion has developed and patented a next generation energy storage device that won the prestigious 2006 Frost & Sullivan Technology Innovation Award for North America in the field of lead-acid batteries. According to Frost & Sullivan, Axion's new PbC batteries have 'the potential to revitalize the lead-acid battery industry by breathing new life into an established technology that was not well-suited to the requirements of important new applications like hybrid electric vehicles and renewable power.'
PbC(TM) batteries use sophisticated carbon electrode assemblies to replace the simple lead-based negative electrodes used by other lead-acid battery manufacturers. The resulting device offers energy storage approaching lead-acid batteries, coupled with far longer cycle life and power output approaching super-capacitors. These low-cost devices recharge rapidly and are environmentally friendly because they use 40% less lead. Axion has been producing prototype PbC batteries at its lead-acid battery plant in New Castle, Pennsylvania for more than a year using the same cases, positive electrodes, separators, electrolytes and manufacturing equipment used in its other lead-acid battery lines. The only notable manufacturing difference is the use of Axion's proprietary carbon electrode assemblies instead of lead- based negative electrodes.
Axion's goal is to become the leading supplier of carbon electrode assemblies for the lead-acid battery industry."
RVTI - Rival Technologies Inc - OTC BB
"In September 2005 Rival Technologies Inc., purchased a technology with the potential to provide an upgrading process for heavy crude and oil sands bitumen. TRU Oiltech Inc was created, laboratory scale research and development rejuvenated, resulting in a next generation primary upgrading technology, the TRU™ process. The process cost effectively produces a premium, pipeline grade, synthetic crude oil branded TRULITE™ and is now ready for continuous feed pilot testing by heavy oil producers and refiners worldwide."
"Rival Technologies is making steady progress towards commercialization of its patented continuous water injection (CWI) technology. We have completed the development of our prototype products, and are currently field testing commercial applications of the technology."
BSHF - Bioshaft Water Technology Inc - OTC BB
"BioShaft is an innovative wastewater treatment technology based on Bio-Filtration utilizing sludge carriers. It is patented in the United Kingdom and the patent is pending in the United States. The plants have many benefits over traditional waste water treatment systems - almost no odor - the plants are considered odorless; the system virtually eliminates sludge, the system has much lower energy consumption, and less significant land requirements. For further information visit the company's website: www.bioshaft.com."
$1.16 - 90m OS - $104m MC
Followers
|
1
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
12
|
Created
|
07/28/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |